ConductScience.org, home

Trial · NCT00399529

Adverse events30

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherFatigueGeneral disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide820
otherUrticariaSkin and subcutaneous tissue disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide720
otherPruritusSkin and subcutaneous tissue disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide620
otherFeverGeneral disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide520
otherFlu-like symptomsGeneral disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide420
otherLymphadenopathyBlood and lymphatic system disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide420
otherAbdominal PainGastrointestinal disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide320
otherRashSkin and subcutaneous tissue disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide320
otherMalaiseGeneral disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide320
otherChillsGeneral disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide320
otherDizzinessNervous system disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide220
otherAnorexiaMetabolism and nutrition disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide120
otherErythemaSkin and subcutaneous tissue disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide120
otherHeadacheNervous system disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide120
otherNauseaGastrointestinal disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide120
otherArm PainMusculoskeletal and connective tissue disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide120
otherCancer Site PainGeneral disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide120
otherLeg PainMusculoskeletal and connective tissue disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide120
otherErythema at Vaccine SitesGeneral disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide2020
otherPruritus at Vaccine SitesGeneral disordersAllo GM-CSF-secreting Vaccine, Trastuzumab, Cyclophosphamide2020

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00399529/events